Abstract |
Umbilical cord mesenchymal stem cells (UC-MSCs) transplantation has become a promising treatment for liver fibrosis. However, UC-MSCs have limited anti- fibrosis ability, and their homing ability of UC-MSCs to the injured liver seems to be poor. In our study, we aimed to determine if the CXCL9-overexpressing UC-MSCs could have synergistic anti- fibrosis effects and whether it can promote the homing ability of UC-MSCs. Overexpression of CXCL9 in UC-MSCs (CXCL9-UC-MSCs) was attained by transfecting the lenti-CXCL9-mCherry to naive UC-MSCs. The therapeutic effect of transducted CXCL9-UC-MSCs on both repairing of hepatic fibrosis and target homing were evaluated by comparing with the control of UC-MSCs transfected with empty lenti-mCherry vector. The results revealed that the liver function of CXCL9-UC-MSCs treated group was significantly improved when compared with that of control UC-MSCs (P < 0.05), and the histopathology indicated an obvious decrease of the collagen fiber content and significant disappearing of pseudo-lobules with basically normal morphology of hepatic lobules. Furthermore, liver frozen sections confirmed that CXCL9-UC-MSCs have significantly stronger chemotaxis and stable persistence in the injured liver tissues. In summary, overexpression of CXCL9 could improve the efficacy of UC-MSCs therapy for liver fibrosis repairing on account of an enhanced ability of UC-MSCs in homing to and staying in the injured sites of liver fibrosis in rat models.
|
Authors | Yang Li, Jiantao Dong, Ye Zhou, Xueshuai Ye, Ziqi Cai, Xueqian Zhang, Li Shen, Mengya Zhang, Wanxing Zhang, Jianhui Cai |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 584
Pg. 87-94
(12 20 2021)
ISSN: 1090-2104 [Electronic] United States |
PMID | 34775285
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- CXCL9 protein, human
- Chemokine CXCL9
|
Topics |
- Animals
- Cell Differentiation
(genetics)
- Cells, Cultured
- Chemokine CXCL9
(genetics, metabolism)
- Disease Models, Animal
- Hepatocytes
(cytology, metabolism)
- Humans
- Liver Cirrhosis
(therapy)
- Male
- Mesenchymal Stem Cell Transplantation
(methods)
- Mesenchymal Stem Cells
(metabolism)
- Rats, Sprague-Dawley
- Transfection
- Transplantation, Heterologous
- Treatment Outcome
- Umbilical Cord
(cytology)
|